NutraResearch
NutraResearch is a Barcelona-based pharmaceutical CDMO providing end-to-end R&D, formulation, regulatory, and custom manufacturing services for dietary supplements, medical devices, and nutricosmetics, serving pharmaceutical firms and supplement brands across Europe as part of the Wellma Group.
- Company typePrivate
- Founded2011
- HeadquartersBarcelona, Spain
- Headcount11–50
- GTM typeB2B
- OfferingServices
What NutraResearch does
NutraResearch is a Barcelona-based pharmaceutical Contract Development and Manufacturing Organization (CDMO) that provides end-to-end research, development, and custom manufacturing services for dietary supplements, medical devices, and nutricosmetic products. Founded in 2011 in L'Hospitalet de Llobregat by pharmaceutical industry veterans Carlos Fernández and Carlos Stampa, the company serves pharmaceutical firms, food supplement brands, and cosmetics companies across Europe. Its service portfolio spans the full product lifecycle: active ingredient (API) selection, formulation development, analytical development, industrialization and technology transfer, regulatory dossier preparation, and industrial-scale manufacturing. The company operates a development center and pilot plant at its L'Hospitalet headquarters and a 24/7 three-shift production plant in Barberà del Vallès, the latter acquired in 2021 through the NutraProcés transaction that vertically integrated manufacturing into the platform.
The company's core technology differentiator is its Next-Generation Dietary Supplement Technology Platform, which adapts pharmaceutical-grade controlled-release engineering (including 8+ hour and colon-targeted release profiles) and mucosa bioadhesion chemistry to phytotherapeutic extracts — a class of natural actives whose variability has historically made modified release difficult. In October 2023, NutraResearch also launched the first 100% recyclable blister packaging free of vinyl and aluminum, with moisture barrier performance validated under ICH Q1A stability protocols. The company is a project-based, multi-year B2B enterprise with custom-quoted pricing; revenue is generated through contract R&D services, custom manufacturing (CDMO), and technology transfer. It is part of the Swedish Wellma Group following a January 2025 strategic integration, and participates in the EU-funded SUSTAINEXT consortium (21 companies, 54 months) targeting 40 new active ingredients from sustainable plant cultivation. In April 2025 it became the first food supplement company worldwide to obtain ISO 56001 Innovation Management certification.
NutraResearch firmographics
Firmographics- Name
- NutraResearch
- Legal name
- Nutraresearch 2011, S.L.
- Website
- https://nutraresearch.es
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- NutraResearch is a Barcelona-based pharmaceutical CDMO providing end-to-end R&D, formulation, regulatory, and custom manufacturing services for dietary supplements, medical devices, and nutricosmetics, serving pharmaceutical firms and supplement brands across Europe as part of the Wellma Group.
- Ownership category
- akta.pro rank
NutraResearch industry classification
Industry- Product category
- Contract Pharmaceutical and Nutraceutical Manufacturing
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
- akta.pro secondary industry
- Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ)
Keywords
Where NutraResearch is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Offices2 records
Markets served
NutraResearch business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Contract R&D Services: Full-service research and development for pharmaceutical and nutraceutical products, including formulation development, analytical development, and registration dossier preparation. Services range from active substance selection through market-ready product development.
- Custom Manufacturing (CDMO): Contract manufacturing of dietary supplements, medical devices, and nutraceutical cosmetics at industrial scale. Following acquisition of Nutraprocés, NutraResearch operates both development pilot plant and production facilities.
- Technology Transfer Services: Transfer of manufacturing methods and processes to client facilities, enabling clients to produce products internally after development.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Project-based pricing for R&D and manufacturing services |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
NutraResearch product offering
Product offeringCore offering
NutraResearch is a Barcelona-based CDMO providing contract R&D, formulation development, analytical services, technology transfer, registration dossier preparation, and industrial-scale custom manufacturing for pharmaceutical and nutraceutical companies. The company applies pharmaceutical-grade technologies — including controlled-release platforms, bioadhesion, and sustainable blister packaging — to develop and manufacture next-generation food supplements, medical devices, and nutraceutical cosmetics.
Product overview
NutraResearch is a leading Barcelona-based CDMO (Contract Development and Manufacturing Organization) specializing in research, development, technology transfer, and custom manufacturing of next-generation food supplements, medical devices, and nutraceutical cosmetics. The company operates as a unified service and product platform offering comprehensive R&D services (API selection, formulation development, analytical development, industrialization, tech transfer, and registration dossiers) alongside a portfolio of 14 dietary supplement product categories covering sports nutrition, skin care, hair care, joint health, weight control, cleansing, anti-stress, veterinary, gynecological, eye care, intestinal health, metabolism regulation, antioxidants, and sleep support. Key technological differentiators include a next-generation controlled-release tablet platform (adapted from pharmaceutical technology), bioadhesion technology for liquid supplements, and the first 100% recyclable sustainable blister packaging. The company, now part of the Swedish Wellma Group following a January 2025 acquisition, serves pharmaceutical and supplement firms across Europe.
Differentiator
Problem solved
Functional benefit
Products and services
- API Selection Service Expert fitotherapy and botany services for selecting active ingredients that form the basis for product effectiveness, provided to pharmaceutical and nutraceutical client companies.
- Formulation Development Service Pharmaceutical technology expertise to formulate active ingredients into effective and stable products with optimal release at the point of action, provided to pharmaceutical and supplement companies.
- Analytical Development Service Partner-provided analytical tools for conducting necessary analytical determinations for new product development, available to pharmaceutical and nutraceutical clients.
- Industrialization and Tech Transfer Service Comprehensive industrialization services including custom manufacturing through Nutraprocés plant and tech transfer to client facilities for pharmaceutical and supplement brands.
- Registration Dossier Service Preparation with extensive in-house experience of registration dossiers for new products and modifications of registration dossiers for existing products, serving pharmaceutical and nutraceutical companies.
- Custom Manufacturing (CDMO) Contract manufacturing of dietary supplements, medical devices, and nutraceutical cosmetics at industrial scale through the production plant in Barberà del Vallès, operating 24/7 in three shifts.
- Sport Nutrition Supplements Dietary supplements formulated for athletic performance, muscle recovery, and sports-related nutritional support.
- Skin Care Supplements Nutraceutical products targeting skin health and beauty from within, utilizing advanced formulation technologies.
- Capillary Care Products Dietary supplements formulated to support hair health, strength, and growth.
- Osteoarticular Supplements Supplements designed to support joint health, bone strength, and musculoskeletal system function.
- Weight Control Products Dietary supplements formulated to support weight management and metabolic health.
- Veterinary Products Nutraceutical formulations designed specifically for animal health applications.
- Sustainable Blister Packaging First 100% recyclable blister packaging free from vinyl and aluminum, providing moisture protection equivalent to 120-gram PVDC coating, validated through ICH Q1A stability studies.
Quantifiable outcome
- First food supplement company worldwide to achieve ISO 56001 certification (April 2025)
- +3 more outcomes
Companies that use NutraResearch
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
NutraResearch technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
NutraResearch partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- WellmacoreStrategic partnership joining NutraResearch with Wellma, a leading European nutraceutical and pharmaceutical CDMO with €100M+ in sales. The partnership expands NutraResearch's access to broader product portfolio and greater R&D capabilities, while strengthening Wellma's pan-European presence. NutraResearch operates as part of Wellma's ecosystem while maintaining entrepreneurial culture. Christian Merup is CEO of Wellma.
- SUSTAINEXT ConsortiumcoreEuropean consortium project (54 months duration) funded by Circular Bio-based Europe Joint Undertaking (CBE JU), bringing together 21 companies to cultivate medicinal plants for nutraceutical and biofuel applications. NutraResearch serves as expert in phytotherapy and galenic formulation, transforming plant extracts into dietary supplements. Project aims to replace tobacco cultivation in Extremadura with medicinal plants and achieve zero waste/zero emissions. Natac leads and coordinates the project.
- NataccoreSpanish company and leader in sustainable botanical extracts production. Manages the biorefinery plant in Hervás (Extremadura) and coordinates the SUSTAINEXT project. Responsible for transforming plant by-products (olive leaves, artichoke, thistle, chamomile) into high-value extracts and active ingredients for pharmaceutical, cosmetic, fertilizer, and bioplastic products. NutraResearch transforms these extracts into dietary supplements.
- Afepadi (Asociación Española de Complementos Alimenticios)minorSpanish Association of Food Supplements of which NutraResearch is a member, providing industry representation and networking within the Spanish supplements sector.
- Circular Bio-based Europe Joint Undertaking (CBE JU)coreEuropean consortium formed by EU and Bio-based Industries Consortium that funds the SUSTAINEXT project. First project funded by CBE JU, representing €XX million in European support for bio-based industry innovation.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
NutraResearch competitors and assessment
Company assessmentDirect peers
- Fagron: Global supplier of pharmaceutical compounding ingredients, nutraceutical raw materials, and personalized medicine solutions headquartered in the Netherlands. Fagron overlaps directly with NutraResearch's nutraceutical formulation and ingredient selection services.
- Roelmi HPC: Italian nutraceutical CDMO specializing in development and contract manufacturing of dietary supplements, cosmeceuticals, and functional foods. Roelmi HPC is a direct European peer in the nutraceutical CDMO niche.
- Idifarma: Spanish pharmaceutical CDMO headquartered in Pamplona, specializing in small-molecule solid oral dose development and manufacturing for pharma and nutraceutical clients. Idifarma is the closest direct peer to NutraResearch in size, geography, and service mix.
- Hermes Arzneimittel: German pharmaceutical company offering CDMO services for solid dosage forms, liquids, and semi-solids. Hermes is a mid-sized European CDMO directly comparable to NutraResearch in scope and pharmaceutical-grade operations.
Broad incumbents
- Lonza Group: Swiss global CDMO leader, particularly strong in capsules, oral solids, and integrated drug substance/drug product services. Lonza is a megascale incumbent with overlapping nutraceutical and pharma CDMO offerings.
- Siegfried Holding: Swiss-headquartered global CDMO offering API and finished drug product manufacturing including solid oral dosage forms. Siegfried is a larger Swiss peer operating in the same European CDMO space as NutraResearch.
- Catalent: Major US-headquartered global CDMO (now part of Novo Holdings) with extensive oral solid dose and softgel capabilities. Catalent competes for the same large pharmaceutical contract manufacturing RFPs that NutraResearch targets.
- Aenova Group: One of the largest European pharmaceutical CDMOs, headquartered in Germany, with broad capabilities in solid dosage forms and nutraceutical contract manufacturing. Aenova operates at significantly larger scale than NutraResearch but serves overlapping pharmaceutical and supplement customers.
- Recipharm: Swedish-headquartered global pharmaceutical CDMO acquired by EQT. Recipharm is the corporate sibling of NutraResearch's parent Wellma under Nordic ownership and offers directly comparable CDMO services at much larger scale.
- Almac Group: UK/Northern Ireland-headquartered global pharmaceutical CDMO offering API manufacturing, drug product development, and clinical supply services. Almac competes at higher scale for multinational pharmaceutical CDMO contracts.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
NutraResearch social profiles
Digital presenceNutraResearch compliance and trust
Trust signalCompliance1 record
NutraResearch financial estimates
Financial estimateRevenue estimate
Valuation estimate
NutraResearch leadership team
Management profileNumber of profiles
Profiles7 records
NutraResearch funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NutraResearch M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NutraResearch
What does NutraResearch do?
NutraResearch is a Barcelona-based CDMO providing contract R&D, formulation development, analytical services, technology transfer, registration dossier preparation, and industrial-scale custom manufacturing for pharmaceutical and nutraceutical companies. The company applies pharmaceutical-grade technologies — including controlled-release platforms, bioadhesion, and sustainable blister packaging — to develop and manufacture next-generation food supplements, medical devices, and nutraceutical cosmetics.
Is NutraResearch a public or private company?
NutraResearch is a private company. It is classified as corporate owned and is currently operating.
When was NutraResearch founded?
NutraResearch was founded in 2011. It employs 11 to 50 people.
Where is NutraResearch based?
NutraResearch is headquartered in Barcelona, Spain, in the Europe region.
How does NutraResearch make money?
Three revenue lines are on record. Contract R&D Services are the primary driver. The others are custom Manufacturing (CDMO) and technology Transfer Services.
Who are NutraResearch's main competitors?
Direct peers on record are Fagron, Roelmi HPC, Idifarma and Hermes Arzneimittel. Broad incumbents are Lonza Group, Siegfried Holding, Catalent, Aenova Group, Recipharm and Almac Group.
Does NutraResearch have an API?
No public API is recorded for NutraResearch.
What industry is NutraResearch in?
NutraResearch's product category is Contract Pharmaceutical and Nutraceutical Manufacturing. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGABAJ, Packaging, Labeling & Serialization (Clinical/Commercial) CDMO. Its NAICS code is 3254 and its SIC code is 2833.